← Back to Clinical Trials
Recruiting NCT06862609

NCT06862609 QIPB in Inguinal Hernia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06862609
Status Recruiting
Phase
Sponsor Konya City Hospital
Condition Postoperative Pain
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-03-23
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Quadro iliac plane blockControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2025-03-23 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Inguinal hernia repair is one of the most commonly performed surgical procedures. It is generally performed under regional anesthesia techniques, such as local anesthesia, peripheral nerve blocks, or neuraxial anesthesia (spinal or epidural anesthesia), or under general anesthesia. Despite various available analgesic regimens, numerous studies have demonstrated that postoperative pain control remains inadequate. Opioids, nonsteroidal anti-inflammatory drugs, and analgesics are frequently used for postoperative pain management. However, these medications are associated with uncertain efficacy and undesirable side effects. Pain is a critical factor in the postoperative period, contributing to delayed ambulation and paralytic ileus, ultimately hindering early discharge.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18-65 years * Undergoing elective, * unilateral laparoscopic inguinal hernia repair * Receiving general anesthesia Exclusion Criteria: * Patients who refuse to provide consent * Patients with contraindications to regional anesthesia * Patients with impaired consciousness * Patients with coagulopathy * Patients with infections at the block site * Emergency cases

Frequently Asked Questions

Who can join the NCT06862609 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06862609 currently recruiting?

Yes, NCT06862609 is actively recruiting participants. Visit ClinicalTrials.gov or contact Konya City Hospital to inquire about joining.

Where is the NCT06862609 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT06862609 clinical trial?

NCT06862609 is sponsored by Konya City Hospital. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology